Merck KGaA (OTCMKTS:MKGAF) Shares Down 7.1% – What’s Next?

Merck KGaA (OTCMKTS:MKGAFGet Free Report)’s share price was down 7.1% on Wednesday . The stock traded as low as $147.8610 and last traded at $147.8610. Approximately 195 shares traded hands during trading, a decline of 62% from the average daily volume of 507 shares. The stock had previously closed at $159.2210.

Merck KGaA Price Performance

The stock has a fifty day moving average of $144.31 and a 200 day moving average of $135.89. The stock has a market cap of $20.35 billion, a price-to-earnings ratio of 24.03 and a beta of 0.96. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84.

About Merck KGaA

(Get Free Report)

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.

Read More

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.